Vector Borne News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") contributed to the development of a pediatric formulation to treat schistosomiasis as a member of the Pediatric Praziquantel Consortium (Consortium). The Consortium announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive scientific opinion for arpraziquantel to treat one of the neglected tropical diseases, schistosomiasis, in preschool-aged chi

The suspicious letters were sent to vote centers and government buildings in six states this month.

By Stephen Nakrosis The Food and Drug Administration said it granted approval of Ixchiq, the first vaccine for chikungunya virus, to Valneva Austria. Valneva...

DIMAPUR — To review the activities undertaken to prevent the spread of dengue as well as discuss measures to be adopted to tackle the rising cases in

DIMAPUR, NOVEMBER 3 (MExN): A meeting of the State Task Force Team (STF) on Vector Borne and Other Communicable Diseases was convened by V Kezo, Commissioner & Secretary, H&FW on November 3 at the Conference Hall of Health & Family Welfare Department, Nag